Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the University of Edinburgh to commercialise its breakthrough Synthetic Super-Enhancer platform, Odysseus, to enable ...

Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a ...

The company's proprietary Synthetic Super-Enhancers (SSEs) are engineered DNA elements that act as docking stations for transcription factors uniquely expressed in aggressive cancer cells. This ...

A new AI model leverages deep learning to understand the binding of transcription factors to DNA, focusing on the process of ...

A breakthrough tool called Helicase-Assisted Continuous Editing (HACE) allows scientists to create precise genetic mutations ...

An international team of researchers has achieved an unprecedented milestone: the creation of mouse stem cells capable of ...

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

Cell-free DNA can be used for non-invasive cancer detection and disease monitoring to enhance personalized medicine.